Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Clarification On Price Movement

 We are in receipt of your letter bearing ref: No.: L/SURV/ONL/PV/RS/ 2021-2022 / 189 dated 10th May, 2021, seeking clarification on movement in price of shares of the Company across the exchanges, in the recent past. In this context, we wish to inform you that there is no information/announcement (including impending announcement) in terms of Regulation 30 of the SEBI (LODR) Regulation, 2015, to be made by the Company, which may have a bearing on the operation/performance of the company and consequent movement in share price of the Company in the recent past. The Company is committed to provide all information to the Exchange, which includes all price sensitive information, etc. and which is required to be disclosed under Regulation 30 of SEBI (LODR) Regulations, 2015.
11-05-2021
Bigul

Indraprastha Medical Corporation Ltd - 532150 - Clarification sought from Indraprastha Medical Corporation Ltd

 The Exchange has sought clarification from Indraprastha Medical Corporation Ltd on May 10, 2021 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.The reply is awaited.
10-05-2021
Bigul

Indraprastha Medical Corporation Ltd - 532150 - Certificate Under Regulation 40(10)

 Pursuant to Regulation 40(10) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed please find a copy of the certificate from a practicing Company Secretary certifying that all certificates have been issued, for the half year ended 31st March, 2021, within 30 days of the date of lodgment for transfer, This is for your information and record.
20-04-2021
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Statement Of Investor Complaints For The Quarter Ended March 2021

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 017170 Name of the Signatory :- PRIYA RANJANDesignation :- Company Secretary and Compliance Officer
13-04-2021
Bigul

Indraprastha Medical Corporation Ltd - 532150 - Shareholding for the Period Ended March 31, 2021

 Indraprastha Medical Corporation Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2021. For more details, kindly Click here
13-04-2021
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 In compliance of Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, enclosed please find herewith a Certificate dated 5th April, 2021, issued by M/s. Link Intime India Private Limited, Registrar & Share Transfer Agent of the Company, for the quarter ended 31st March, 2021. This is for your information and record.
10-04-2021
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Compliance Certificate For The Half Year Ended 31-03-2021

 Pursuant to Regulation 7(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed please find the compliance certificate for the half year ended 31st March, 2021. This is for your information and record.
09-04-2021
Bigul

Indraprastha Medical Corporation Ltd - 532150 - Announcement under Regulation 30 (LODR)-Change in Directorate

 This is to inform you that the Board of Directors of the Company at its meeting held on 7th April, 2021, have:- 1. Appointed Mr. Udit Prakash Rai (DIN: 07573658) as an Additional Director (Nominee Director of Govt. of NCT of Delhi) of the Board of Directors of the Company w.e.f. 7th April, 2021. As an Additional Director, he holds office of Director only up to the next Annual General Meeting (AGM) , and shall seek the approval of the shareholders at AGM for his appointment as a Director of the Company ; and 2. Appointed Mr. Vikram Bhat (DIN: 09076418) as an Additional Director (Nominee Director of Govt. of NCT of Delhi) of the Board of Directors of the Company w.e.f. 7th April, 2021. As an Additional Director, he holds office of Director only up to the next Annual General Meeting (AGM), and shall seek the approval of the shareholders at AGM for his appointment as a Director of the Company. A brief resume of the Directors appointed is attached.
07-04-2021
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Closure of Trading Window

 Pursuant to the provisions of the Code of Conduct for Prevention of Insider Trading, under SEBI (Prohibition of Insider Trading) Regulations, 2015, it is hereby informed that Trading Window for dealing in shares of the Company, will remain closed with effect from 1st April, 2021 till 48 hours after the declaration of audited financial results for the quarter / year ending 31st March, 2021. The date of the Board Meeting to consider the audited financial results for the quarter / financial year ending 31st March, 2021, shall be intimated separately. This is for your information and record.
30-03-2021
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Pursuant to the provisions of Regulation 39 of the the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith a statement of Duplicate Share Certificates issued by the Company in respect of Share Certificates reported to be lost by the shareholder.
20-02-2021
Next Page
Close

Let's Open Free Demat Account